Antimicrobial

LL-37 is a 37-amino acid linear peptide belonging to the cathelicidin family of antimicrobial peptides (AMPs). In preclinical and biochemical research settings, this molecule is utilized to investigate the following biological mechanisms:Antimicrobial Pathways: Studied for its membrane-disrupting capabilities and broad-spectrum interaction profiles with microbial cell envelopes. Immunomodulatory Signaling: Observed in laboratory models for its involvement in autoimmune joint pathways, cytokine signaling regulation, and tissue homeostasis mechanisms.This compound is a high-purity research-grade peptide supplied strictly for laboratory use and scientific experimentation. Not for diagnostic or therapeutic use.

Made to Order Compound ✦ Price on Request. Contact us LZ1 is characterized as a 15-residue cationic antimicrobial peptide with: - Strong activity against Gram-positive skin pathogens and certain antibiotic-resistant strains - Negligible hemolytic activity and low cytotoxicity toward keratinocytes - Observed anti-inflammatory effects through modulation of TNF-α and IL-1β pathways - Documented antimalarial activity associated with inhibition of parasite energy metabolism These properties make LZ1 a relevant compound for experimental research in antimicrobial mechanisms, inflammatory signaling, and skin biology.

Ovagen is a bioregulatory peptide that has been studied for its role in supporting gastrointestinal mucosal integrity and maintaining normal liver tissue structure. Research suggests it may help protect the gastrointestinal mucosal layer from stressors such as antibiotics, toxins, and anti-inflammatory agents, while also being associated with reduced fibrotic processes in liver tissue. Ongoing experimental studies are further evaluating Ovagen’s interaction with mechanisms involved in HIV viral replication. FRESHLY PREPARED SOLUTION 

Ovagen is a bioregulatory peptide that has been studied for its role in supporting gastrointestinal mucosal integrity and maintaining normal liver tissue structure. Research suggests it may help protect the gastrointestinal mucosal layer from stressors such as antibiotics, toxins, and anti-inflammatory agents, while also being associated with reduced fibrotic processes in liver tissue. Ongoing experimental studies are further evaluating Ovagen’s interaction with mechanisms involved in HIV viral replication.

Ovagen is a bioregulatory peptide that has been studied for its role in supporting gastrointestinal mucosal integrity and maintaining normal liver tissue structure. Research suggests it may help protect the gastrointestinal mucosal layer from stressors such as antibiotics, toxins, and anti-inflammatory agents, while also being associated with reduced fibrotic processes in liver tissue. Ongoing experimental studies are further evaluating Ovagen’s interaction with mechanisms involved in HIV viral replication.

RTD-1 is a macrocyclic θ-defensin peptide expressed in Old World monkeys and studied for its broad-spectrum antibacterial, antifungal, and antiviral activity. Research indicates it may function by interacting with microbial membranes while also exerting significant immunomodulatory effects. Notably, experimental studies in a rodent model of rheumatoid arthritis showed that RTD-1 rapidly suppressed and reversed autoimmune joint disease, improving mobility and preserving joint structure. Mechanistically, RTD-1 reduced joint IL-1β levels, inhibited IL-6 production, suppressed fibroblast-like synoviocyte invasiveness, and inhibited destructive proteases such as ADAM17/ADAM10, metalloproteases, and cathepsin K. These properties have positioned RTD-1 as a promising research peptide of interest in antimicrobial defense and inflammation-related disease models.